Ann Mariuk-Jarema, MD

Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Mazowieckie, Poland

Presentation(s):

• Paper 15 - PRIMARY ENDPOINT AND TRANSLATIONAL CORRELATES FROM EFTISARC-NEO: PHASE II TRIAL OF NEOADJUVANT EFTILAGIMOD ALPHA (EFTI), PEMBROLIZUMAB AND RADIOTHERAPY IN PATIENTS WITH RESECTABLE SOFT TISSUE SARCOMA

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.

• Paper 55 - INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY OF SPINDLE CELL/ SCLEROSING RHABDOMYOSARCOMA, A PUSH PLATFORM STUDY

  Friday, November 14, 2025
  5:00 PM - 6:00 PM EST

  Disclosure information not submitted.